Robert Michael Dudley, CEO: Transcode Therapeutics RNAZ Buy · Filed 23/10/02

Trade details

Type: Insider buy
Amount: $49,980
Shares · price: 98,000 sh · $0.51 a share
Held after: 180,262 sh
Stock: Transcode Therapeutics RNAZ
Person: Robert Michael DudleyCEO
Trade date: 23/09/28
Filed: 23/10/02
Days to filing: 4 days

2 insiders bought this week

Insiders buying this week: 2 insiders
Holding change: +119.1%

Transcode Therapeutics trades, last 26 weeks

What else happened in Transcode Therapeutics around then

Filed or reported within 30 days of the trade day · 23/08/29~23/10/28

Robert Michael Dudley's recent trades

Robert Michael DudleyCEO
BuyTranscode Therapeutics
Buy
Transcode Therapeutics
RNAZ
$31.8K
12,000 sh
$31.8K
Filed 23/06/22
Traded 23/06/21
Robert Michael DudleyCEO
BuyTranscode Therapeutics
Buy
Transcode Therapeutics
RNAZ
$16.8K
6,607 sh
$16.8K
Filed 23/06/22
Traded 23/06/20
Robert Michael DudleyCEO
BuyTranscode Therapeutics
Buy
Transcode Therapeutics
RNAZ
$52.4K
19,000 sh
$52.4K
Filed 23/06/14
Traded 23/06/09
Robert Michael DudleyCEO
BuyTranscode Therapeutics
Buy
Transcode Therapeutics
RNAZ
$52.4K
19,000 sh
$52.4K
Filed 23/06/13
Traded 23/06/09